0000950170-23-065866.txt : 20231122
0000950170-23-065866.hdr.sgml : 20231122
20231122160533
ACCESSION NUMBER: 0000950170-23-065866
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231103
FILED AS OF DATE: 20231122
DATE AS OF CHANGE: 20231122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucchino David L.
CENTRAL INDEX KEY: 0001785288
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39062
FILM NUMBER: 231433421
MAIL ADDRESS:
STREET 1: C/O FREQUENCY THERAPEUTICS, INC.
STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR
CITY: WOBURN
STATE: MA
ZIP: 01801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Korro Bio, Inc.
CENTRAL INDEX KEY: 0001703647
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472324450
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE. BUILDING 600-700
STREET 2: SUITE 6-401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-468-1900
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE. BUILDING 600-700
STREET 2: SUITE 6-401
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Frequency Therapeutics, Inc.
DATE OF NAME CHANGE: 20170412
4
1
ownership.xml
4
X0508
4
2023-11-03
0001703647
Korro Bio, Inc.
KRRO
0001785288
Lucchino David L.
C/O KORRO BIO, INC.
ONE KENDALL SQUARE, BUILDING 600-700
CAMBRIDGE
MA
02139
true
false
false
false
false
Common Stock
2023-11-03
4
M
false
5600
A
18274
D
Common Stock
2023-11-03
4
A
false
6000
A
24274
D
Common Stock
2023-11-10
4
S
false
37
37.9242
D
24237
D
Common Stock
2023-11-10
4
S
false
373
39.5889
D
23864
D
Common Stock
2023-11-10
4
S
false
41
41.9427
D
23823
D
Common Stock
2023-11-10
4
S
false
225
43.1720
D
23598
D
Common Stock
2023-11-10
4
S
false
191
44.0134
D
23407
D
Common Stock
2023-11-10
4
S
false
67
45.5281
D
23340
D
Common Stock
2023-11-10
4
S
false
34
46.2250
D
23306
D
Restricted Stock Units
2023-11-03
4
M
false
5600
0.00
D
Common Stock
5600
0
D
Reflects shares of the Issuer's common stock received upon vesting of restricted stock units ("RSUs") granted January 26, 2023 as adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
Total number of shares of common stock is adjusted for a 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
Reflects shares of the Issuer's common stock received upon execution of a separation agreement effective November 3, 2023 resulting in vesting of performance RSUs granted April 11, 2022, as adjusted for the 1-for-50 reverse stock split effected by the Issuer on November 3, 2023.
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs, and does not represent a discretionary trade by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.575 to $37.955, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.155 to $40.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.45 to $42.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.75 to $43.625, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.87 to $44.175, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.07 to $46.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
/s/ David L. Lucchino
2023-11-22